Foghorn Therapeutics (FHTX) Stock Highlights

5.14 | +3.21%

2024-12-21 05:24:43

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Statistics

Range Today

4.88 5.28

Volume Today 443.8K

Range 1 Year

2.7 10.25

Volume 1 Year 35.03M

Range 3 Year

2.7 24.34

Volume 3 Year 88.83M

Range 10 Year

2.7 28.26

Volume 10 Year 150.52M

Highlights

Market Capitalization 519.8M (small)

Floating Shares 26.15M

Current Price 5.14

Price To Earnings -4.76

Price To Revenue 11.42

Earnings Per Share -1.9

Payout Ratio 0%

Performance

Latest +3.21%

1 Month -33.93%

3 Months -46.74%

6 Months -0.77%

1 Year -10.76%

3 Years -72.28%

5 Years -72.95%

10 Years -72.95%

Benchmarks

Market Capitalization

201 / 368

Gross Profits

230 / 278

Total Revenue

141 / 300

Total Rank

128 / 368

Free Cashflow

234 / 352

Performance 5 years

212 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.